TwinBeech Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
1,454
-855
-37% -$874K 0.32% 101
2026
Q1
$2.12M Buy
+2,309
New +$2.34M 0.22% 140
2025
Q1
Sell
-80,411
Closed -$62.1M 846
2024
Q4
$62.1M Buy
+80,411
New +$66.6M 1.06% 18
2024
Q2
Sell
-6,419
Closed -$4.99M 698
2024
Q1
$4.99M Buy
+6,419
New +$4.57M 0.1% 211
2022
Q2
Sell
-13,352
Closed -$3.82M 622
2022
Q1
$3.82M Buy
+13,352
New +$3.44M 0.17% 168

Other funds holding LLY

TwinBeech Capital's LLY Position: Q2 2026 in Review

TwinBeech Capital reduced its Eli Lilly (LLY) stake by 37% in Q2 2026, selling an estimated $874K and leaving 1,454 shares worth $1.74M. The position accounts for 0.32% of the portfolio, ranked #101.

TwinBeech Capital first reported a position in LLY in Q1 2022 and has held it in 5 quarters since. The position peaked at $62.1M in Q4 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TwinBeech Capital held 1,454 shares of Eli Lilly worth $1.74M as of Q2 2026.
  • TwinBeech Capital sold 855 Eli Lilly shares in Q2 2026, an estimated $874K.
  • Eli Lilly made up 0.32% of TwinBeech Capital's portfolio in Q2 2026, its #101 holding.
  • TwinBeech Capital first reported a position in Eli Lilly in Q1 2022 and has held it in 5 quarters since.
  • TwinBeech Capital's Eli Lilly position peaked at $62.1M in Q4 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.